Clinical Trial: Extended Post-operative Oral TXA in Primary THA

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685743) titled 'Extended Post-operative Oral TXA in Primary THA' on June 29.

Brief Summary: The goal of this clinical trial is to learn if extended post-operative oral tranexamic acid (TXA) - a medication that reduces bleeding by slowing the breakdown of blood clots - can improve functional recovery following surgery in adults undergoing primary total knee or hip arthroplasty for osteoarthritis. The main question it aims to answer is: Does extended post-operative oral TXA improve functional outcomes at 6 weeks post-operatively compared to standard perioperative TXA alone? Researchers will compare patients receiving extended oral TXA to patients rece...